Symposium

716154 - Symposium: Bone Graft Substitutes in Spinal Surgery: Classification, Evidence and Coverage Criteria

Thursday, February 27, 2020

3:00 PM – 4:00 PM

Location: Ballroom B

Participants should be aware of the following financial/non-financial relationships:

Gunnar Andersson, MD, PhD: Biometrix (Individual(s) Involved: Self, Products/Services: Stockholder): Stockholder; Integrity Implants (Individual(s) Involved: Self, Products/Services: Stockholder): Stockholder; Novadip (Individual(s) Involved: Self, Products/Services: Consultant): Consultant; Orthofix (Individual(s) Involved: Self, Products/Services: Consultant): Consultant; Riley Pharmaceutical (Individual(s) Involved: Self, Products/Services: Stockholder): Stockholder; Theracell (Individual(s) Involved: Self, Products/Services: Consultant): Consultant, stockholder

Chris Arts, PhD: Bonalive (Individual(s) Involved: Self, Products/Services: advisory board member): consultancy fee paid to hospital not to self; Cerapedics (Individual(s) Involved: Self, Products/Services: advisory board member, speakerbureau member): consultancy fee paid to hospital not self

Zorica Buser, PhD: Cerapedics (Individual(s) Involved: Self, Products/Services: Consulting): Consulting

Morgan P. Lorio, MD: I do not have any relevant financial / non-financial relationships with any proprietary interests.

Christopher Chaput, MD: Globus (Individual(s) Involved: Self, Products/Services: Quartex Posterior Cervical System): Royalties; Johnson & Johnson (Individual(s) Involved: Self, Products/Services: Exparel): Speakers bureau; Nuvasive (Individual(s) Involved: Self, Products/Services: Lateral interbody cages): research support provided to my employer

Agenda:
• ISASS Recommendations and Coverage Criteria for Bone Graft Substitutes used in Spinal Surgery: An Overview
• Demineralized bone matrices in Spine Surgery
• Cellular Based Allografts
• Class III Drug Device Combination Products
• Clinical Perspective, Coverage Implications, Wrap-Up
• Panel Discussion

Speaker(s)

Gunnar Andersson, MD, PhD

Disclosure: Biometrix : Stockholder (Status: Ongoing); Integrity Implants : Stockholder (Status: Ongoing); Novadip : Consultant (Status: Ongoing); Orthofix : Consultant (Status: Ongoing); Riley Pharmaceutical : Stockholder (Status: Ongoing); Theracell : Consultant, stockholder (Status: Ongoing)
Chris Arts, PhD

associate professor translational biomaterials
Maastricht University Medical Centre

Disclosure: Bonalive : consultancy fee paid to hospital not to self (Status: Ongoing); Cerapedics : consultancy fee paid to hospital not self (Status: Ongoing)
Zorica Buser, PhD

Assistant Professor of Research Orthoapedic Surgery and Neurological Surgery
Keck School of Medicine, University of Southern California

Disclosure: Cerapedics : Consulting (Status: Ongoing)
Morgan P. Lorio, MD

Surgeon
Advanced Orthopedics and Pain Management

Disclosure: I do not have any relevant financial / non-financial relationships with any proprietary interests.
Christopher Chaput, MD

Flawn Endowed Professor of Spinal Disorders
UT Health San Antonio

Disclosure: Globus : Royalties (Status: Ongoing); Johnson & Johnson : Speakers bureau (Status: Ongoing); Nuvasive : research support provided to my employer (Status: Ongoing)